Cone Beam Computed Tomography for the Interventional Oncologist: A Practical Approach

Abstract

Transarterial treatment of liver tumors is becoming increasingly common and is considered first- or second-line therapy for many tumor types and stages. Such therapies are heavily dependent on imaging during the procedures; while angiography remains the mainstay of intraprocedural therapies, cone beam computed tomography (CBCT) is becoming increasingly commonly used to guide therapy. This article describes the role of CBCT during transarterial therapies and offers guidance as to how CBCT can be optimally used for these procedures.

Keywords

interventional radiology - chemoembolization - radioembolization - hepatocellular carcinoma - cone beam computed tomography

Publication History

Article published online:
19 August 2024

• References

• 1 Orth RC, Wallace MJ, Kuo MD. Technology Assessment Committee of the Society of Interventional Radiology. C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol 2008; 19 (06) 814-820
• 2 Biondetti P, Ierardi AM, Casiraghi E. et al. Clinical impact of a protocol involving cone-beam CT (CBCT), fusion imaging and ablation volume prediction in percutaneous image-guided microwave ablation in patients with hepatocellular carcinoma unsuitable for standard ultrasound (US) guidance. J Clin Med 2023; 12 (24) 7598
• 3 Abi-Jaoudeh N, Fisher T, Jacobus J. et al. Prospective randomized trial for image-guided biopsy using cone-beam CT navigation compared with conventional CT. J Vasc Interv Radiol 2016; 27 (09) 1342-1349
• 4 Grosse U, Syha R, Ketelsen D. et al. Cone beam computed tomography improves the detection of injured vessels and involved vascular territories in patients with bleeding of uncertain origin. Br J Radiol 2018; 91 (1088) 20170562
• 5 Pung L, Ahmad M, Mueller K. et al. The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. J Vasc Interv Radiol 2017; 28 (03) 334-341
• 6 Llovet JM, Real MI, Montaña X. et al; Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359 (9319) 1734-1739
• 7 May BJ, Murthy R, Madoff DC. What's new in transarterial therapies for hepatocellular carcinoma?. Gastrointest Cancer Res 2012; 5 (3, Suppl 1): S14-S19
• 8 Kim E, Sher A, Abboud G. et al. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study. Lancet Gastroenterol Hepatol 2022; 7 (09) 843-850
• 9 Mulcahy MF, Mahvash A, Pracht M. et al; EPOCH Investigators. Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, Phase III trial. J Clin Oncol 2021; 39 (35) 3897-3907
• 10 Bhalani SM, Lewandowski RJ. Radioembolization complicated by nontarget embolization to the falciform artery. Semin Intervent Radiol 2011; 28 (02) 234-239
• 11 Newgard BJ, Getrajdman GI, Erinjeri JP. et al. Incidence and consequence of nontarget embolization following bland hepatic arterial embolization. Cardiovasc Intervent Radiol 2019; 42 (08) 1135-1141
• 12 Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 2002; 224 (02) 542-547
• 13 Iwazawa J, Ohue S, Mitani T. et al. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 2009; 192 (04) 1057-1063
• 14 Kakeda S, Korogi Y, Ohnari N. et al. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol 2007; 18 (12) 1508-1516
• 15 Yao X, Yan D, Jiang X. et al. Dual-phase cone-beam CT-based navigation imaging significantly enhances tumor detectability and aids superselective transarterial chemoembolization of liver cancer. Acad Radiol 2018; 25 (08) 1031-1037
• 16 Schernthaner RE, Haroun RR, Duran R. et al. Improved visibility of metastatic disease in the liver during intra-arterial therapy using delayed arterial phase cone-beam CT. Cardiovasc Intervent Radiol 2016; 39 (10) 1429-1437
• 17 Schernthaner RE, Lin M, Duran R, Chapiro J, Wang Z, Geschwind JF. Delayed-phase cone-beam CT improves detectability of intrahepatic cholangiocarcinoma during conventional transarterial chemoembolization. Cardiovasc Intervent Radiol 2015; 38 (04) 929-936
• 18 Durack JC, Brown KT, Avignon G. et al. Assessment of automated cone-beam CT vessel identification software during transarterial hepatic embolisation: radiation dose, contrast medium volume, processing time, and operator perspectives compared to digital subtraction angiography. Clin Radiol 2018; 73 (12) 1057.e1-1057.e6
• 19 Cornelis FH, Borgheresi A, Petre EN, Santos E, Solomon SB, Brown K. Hepatic arterial embolization using cone beam CT with tumor feeding vessel detection software: impact on hepatocellular carcinoma response. Cardiovasc Intervent Radiol 2018; 41 (01) 104-111
• 20 Prachanronarong K, Kim E. Radiation segmentectomy. Semin Intervent Radiol 2021; 38 (04) 425-431
• 21 Lewandowski RJ, Gabr A, Abouchaleh N. et al. Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma. Radiology 2018; 287 (03) 1050-1058
• 22 Stein SI, Soliman MM, Sparapani J. et al. Conventional hepatic volumetry may lead to inaccurate segmental yttrium-90 radiation dosimetry. Cardiovasc Intervent Radiol 2021; 44 (12) 1973-1985
• 23 Kwak DH, Lionberg A, Patel M. et al. Quantitative differences in volumetric calculations for radiation dosimetry in segmental Y90 treatment planning using hybrid angiography-CT compared with anatomic segmentation. Br J Radiol 2024; 97 (1154) 353-362
• 24 Kim KA, Choi SY, Kim MU. et al. The efficacy of cone-beam CT-based liver perfusion mapping to predict initial response of hepatocellular carcinoma to transarterial chemoembolization. J Vasc Interv Radiol 2019; 30 (03) 358-369
• 25 Chernyak V, Fowler KJ, Kamaya A. et al. Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018; 289 (03) 816-830
• 26 Lucatelli P, De Rubeis G, Ginnani Corradini L. et al. Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure. Eur J Radiol 2020; 124: 108806
• 27 Cho Y, Lee S, Park SJ. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization. PLoS One 2021; 16 (01) e0245911